Navigation Links
Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
Date:5/20/2008

d four to five million men in the U.S. who suffer from hypogonadism. Of this group, less than ten percent are currently receiving treatment with testosterone therapy.

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate cancer, SUPPRELIN(R) LA for central precocious puberty, and DELATESTRYL(R) to treat male hypogonadism. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(TM) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly, and a biodegradable ureteral stent used in association with the adjunctive treatment of kidney stones.

Forward Looking Statements

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties are set forth in the Company's filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under "Risk Factors" and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, VANTAS and SUPPRELIN LA; effectiveness of our sales force; competition and its effect on pricing, spending, third-party relationships and revenues; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
2. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
3. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
4. Indevus Announces Submission of New Drug Application
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
7. Napo Presents at ISPOR Meeting in Toronto
8. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
9. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... N.C. , Sept. 12, 2014 ... device companies increasingly depend upon Health Outcomes Liaison ... with payer organizations, thought leaders, and other important ... and comparative effectiveness data grows, successful companies will ... relatively new field-based HOL function. To ...
(Date:9/12/2014)... 12, 2014 Research ... addition of the  "Patient Handling Equipment Market ... & by End User - Global Forecast ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... lucrative growth potential for the next five ...
(Date:9/12/2014)... -- The report "Food & Beverage ... & Energy Drinks, Others), Food (Fruit & Vegetable, ... Material (Aluminum & Steel) - Global Forecast to ... Food & Beverage Metal Cans Market with analysis ... volumes and values. The application market is sub-segmented ...
Breaking Medicine Technology:Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace 2Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 2Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4
... XIANYANG, China, Oct. 7 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, ... Company"),a Xianyang-based developer, manufacturer and supplier of pharmaceutical,products ... and,conditions, today announced that the Chinese Military Drug ... the Company,s new drug,application, the Zushima Analgesic Aerosol ...
... Oct. 7 Cleveland Clinic,s Top 10 Medical ... techniques and therapies that are being developed to treat everything ... , The list of breakthrough devices and therapies was ... and it was unveiled during Cleveland Clinic,s 2009 ...
Cached Medicine Technology:Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 2Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4
(Date:9/14/2014)... News) -- Getting enough sleep each night may mean you,re less ... new study suggests. The study included more than 3,700 people ... average of seven years. Those who slept less than six ... likely to have extended absences from work due to illness, the ... from work due to sickness were those who slept between seven ...
(Date:9/14/2014)... 2014 Top10BestSEOHosting.com always offers truly ... web host suppliers carefully, the site has announced ... are the Best WordPress Hosting suppliers in the ... a top web hosting provider, and the company’s ... web hosting provider known for its flexible hosting ...
(Date:9/14/2014)... A new DePuy Pinnacle hip lawsuit has ... behalf of a Franklin County, Ohio man who underwent hip ... metal-on-metal hip lawsuit filed against Johnson & Johnson and its ... 40 years old when the Pinnacle Hip device was surgically ... According to the hip implant lawsuit , the man underwent ...
(Date:9/14/2014)... School requires that children read at both near ... screened only for far vision when they enter school. , ... their eyes do not track effectively or focus (team) on ... avoid reading; at worst, they will think there is ... Children who cannot see cannot read. , On November ...
(Date:9/13/2014)... Recently, an experienced supplier of wedding ... its new collection of eggplant evening dresses . ... discounted rates, up to 58% off. According to the ... September 23. , The company’s new items are ... vintage, plus size, modest, sexy outfits and so on. ...
Breaking Medicine News(10 mins):Health News:A Good Night's Sleep May Mean a Good Day's Work 2Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2
... , , ST. PAUL, Minn., ... WorkFit(TM) workstation, a new sit-or-stand mobile computer workstation that enables ... to a seated position whenever they wish - reducing back ... more productive computing. , , The ...
... , , , ... is pleased to announce that is has added a new module ... interactions with patients. "Customer service and employee motivation are two ... their employees," says Dr. Kenneth Beer. , , ...
... , , MEMPHIS, Tenn., ... are seeing donations decline, St. Jude Children,s Research Hospital((R)) is receiving ... of the sixth annual Create-A-Pepper to Fight Childhood Cancer ... will observe National Childhood Cancer Awareness Month by inviting guests to ...
... , , , , ... Health , a comprehensive health care provider in ... Wilson A sfora, MD , ... United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar ...
... SHANGHAI, Aug. 27 /PRNewswire-Asia/ -- Linkwell Corporation (OTC ... disinfectants in China, announced that its 90% held,subsidiary, Shanghai ... Shield of Likang -- The Establishment of One Hundred ... 2009 to September,2010. , The ...
... 27, 2009) In a victory for families who dug ... Institutes of Health has awarded a $3.5-million grant to the ... for human clinical trials in a bid to halt ... human trials within four years, the NIH award was eagerly ...
Cached Medicine News:Health News:New WorkFit Ergonomic Workstations From Ergotron 'Take a Stand' for 21st Century Office Computing 2Health News:New WorkFit Ergonomic Workstations From Ergotron 'Take a Stand' for 21st Century Office Computing 3Health News:St. Jude Children's Research Hospital(R), Chili's(R) Grill & Bar Kick-off Sixth Annual Create-A-Pepper to Fight Childhood Cancer Campaign 2Health News:St. Jude Children's Research Hospital(R), Chili's(R) Grill & Bar Kick-off Sixth Annual Create-A-Pepper to Fight Childhood Cancer Campaign 3Health News:Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510(k) Market Clearance as a Lumbar Intervertebral Body Fusion Device 2Health News:Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510(k) Market Clearance as a Lumbar Intervertebral Body Fusion Device 3Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 2Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 3Health News:NIH grant advances Tay-Sachs disease gene therapy 2Health News:NIH grant advances Tay-Sachs disease gene therapy 3
... continues to raise the standard for rapid, ... x g performance and our new 4x5mL ... sizes from 0.2 ml to 8.3 ml, ... drive, very quiet operation, rotor imbalance detection, ...
... has the highest g-force ever. But optimal ... force. Optima MAX combines maximum force, capacity, ... performance that's worlds apart from any other ... and enhanced efficiency, Optima takes productivity to ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
... of generating 694,000 x g ... rpm, Beckman Coulter's Optima L-90K ... more separations in less time. ... with a broad range of ...
Medicine Products: